Steep Hill Announces Appointment of Director
Toronto, Ontario--(Newsfile Corp. - August 20, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") is pleased to announce that Ms. Sonia Agustina has been appointed as a Director of the Company, effective August 13, 2025. Ms. Agustina is a Chartered Professional Accountant with over 20 years of financial leadership experience in both public practice and industry, specializing in regulated, high-growth, and publicly listed companies. She currently serves
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-08-20 5:00 PM EDT | Steep Hill Inc.
Red Light Holland Applauds HHS Review of Psilocybin Rescheduling Petition, Expresses Optimism for Reversal of Schedule I Classification
Toronto, Ontario--(Newsfile Corp. - August 20, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of magic truffles to the legal, recreational market within the Netherlands, today welcomes the U.S. Drug Enforcement Administration's (DEA) decision to forward a psil
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-08-20 8:43 AM EDT | Red Light Holland Corp.
Optimi Health Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a manufacturer of GMP-certified MDMA and psilocybin, is pleased to announce it has entered into an agreement with MZ Investor Relations ("MZ"), an investor relations firm. MZ will provide Optimi with strategic support in capital markets advisory, corporate communications, and investor engagement. Under the te
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-08-20 7:30 AM EDT | Optimi Health Corp.
Red Light Holland Receives Initial Third-Party Psilocybin Testing Results via FDA-Compliant, DEA-Registered Partner, Irvine Labs
Toronto, Ontario--(Newsfile Corp. - August 18, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporatio
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-08-18 8:16 AM EDT | Red Light Holland Corp.
Neural Announces Completion of the Acquisition of a 30.75% Interest in Hanf.com, a Profitable German CBD Retail Store Chain
Toronto, Ontario--(Newsfile Corp. - August 13, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-08-13 7:30 AM EDT | Neural Therapeutics Inc.
Quantum BioPharma Announces Update to Previously Announced Private Placement
Toronto, Ontario--(Newsfile Corp. - August 11, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that further to its press release dated June 27, 2025, the Company will be seeking shareholder approval of its non-brokered private placement of class A multiple voting shares ("MVS") for aggregate gross
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-08-11 6:32 PM EDT | Quantum BioPharma Ltd.
Numinus Wellness Inc. Announces First Quarter Fiscal 2025 Results
Vancouver, British Columbia--(Newsfile Corp. - August 8, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three months ended November 30, 2024 ("Q1 2025").
2025-08-08 5:00 PM EDT | Numinus Wellness Inc.